• SENSEX 76,999.72
    81.87 (+0.11%)
  • BANKNIFTY 55,540.05
    537.85 (+0.98%)
  • NSE
    1,795.00 1,640.25(%)
  • CIAN Agro
    1,158.00 2,182.90(%)
  • Jio Platforms
    1,432.00 1,356.40(%)
  • BLS Polymers
    277.20 285.25(%)
  • Hind. Unilever
    1,941.65 1,758.60(%)
  • Reliance Industries
    1,304.00 1,152.30(%)
  • Diamond Power
    359.00 115.80(%)
  • Devson Catalyst
    307.60 186.35(%)
  • ICICI Bank
    1,435.00 1,479.90(%)
  • Pashupati Cotsp.
    152.50 148.85(%)
  • HDFC Bank
    723.00 668.90(%)
  • TCS
    2,480.00 1,976.00(%)
  • Lloyds Metals
    1,778.00 1,044.00(%)
  • Bharat Electron
    381.90 473.25(%)
  • Tech Mahindra
    1,793.00 1,850.00(%)
  • SBI
    976.00 1,234.80(%)
  • Coal India
    397.00 369.55(%)
  • Marico
    873.40 889.95(%)
  • Neuland Labs.
    18,599.90 11,500.00(%)
  • Moneyview
    53.82 45.80(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Lyka Labs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 677.0
  • ISIN : INE933A01014
75.57 1 (0.67%)
  • As on 04 Nov 2026 (EOD)

  • Today’s Low

    75.57

  • Today’s High

    75.57

  • Open

    75.57

  • Perv Close

    75.07

  • 52W Low

    44.10

  • 52W High

    96.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    273.21

  • Div & Yield %

    0.00

  • Book Value(₹)

    25.01

  • Debt-Equity Ratio

    0.67

  • AGM Date

    03-Nov-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    1.14

  • Mar.Cap (₹Cr.)

    273.21

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    36.15

  • BV (₹)

    25.00

  • Sales( ₹ in Cr.)

    120.91

  • NP (in Cr.)

    -9.27

  • NP Var(%)

    -218.0

  • Div%

    0.0

  • CPS (₹)

    -0.20

  • EPS (₹)

    -2.60

  • Traded Value (₹ in Lakhs)

    271.15

  • 52 Week High

    96.00

  • 52 Week Low

    44.10

  • Price BSE

    75.0

  • Price NSE

    76.00

  • Market Capital( in Cr.)

    271.15

  • P/C Ratio

    -333.00

  • P/E Ratio

    -29.20

  • Price Vs.BV

    -2.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 120.91 134.70 106.40 80.59 164.35 62.26
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 120.91 134.70 106.40 80.59 164.35 62.26
Other Income 3.97 2.76 1.65 3.45 2.72 2.21
Stock Adjustments 1.08 1.37 0.79 1.21 0.40 -2.04
Total Income 125.96 138.83 108.84 85.25 167.47 62.43
EXPENDITURE :            
Raw Materials 46.57 54.60 43.73 30.27 31.27 21.48
Power and Fuel Cost 4.24 3.90 3.92 3.57 3.88 2.91
Employee Cost 41.60 34.40 26.01 17.48 16.22 13.03
Other Manufacturing Expenses 4.92 5.22 4.49 2.81 2.25 2.27
Selling and Administration Expenses 19.17 19.09 13.20 11.18 12.04 5.63
Miscellaneous Expenses 30.90 1.46 1.33 8.06 6.26 1.91
Employee Benefit Expenses 41.60 34.40 26.01 17.48 16.22 13.03
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 147.40 118.66 92.68 73.37 71.93 47.22
Operating Profit -21.45 20.17 16.15 11.88 95.55 15.20
Interest 3.33 2.30 4.80 11.57 19.92 25.55
Gross Profit -24.78 17.87 11.35 0.31 75.63 -10.35
Depreciation 8.46 6.77 12.29 13.52 15.39 8.05
Profit Before Tax -33.24 11.10 -0.94 -13.21 60.24 -18.40
Current Tax 0.83 2.73 1.60 0.21 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -1.77 0.46 -0.26 -0.13 20.34 -3.94
Reported Net Profit -32.29 7.92 -2.27 -13.29 39.90 -14.46
Extraordinary Items -23.01 0.03 0.04 -7.06 -3.09 -1.43
Adjusted Net Profit -9.28 7.89 -2.31 -6.23 42.99 -13.03
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -112.42 -120.33 -101.38 -88.09 -127.99 -113.54
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -144.70 -112.42 -103.65 -101.38 -88.09 -127.99
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -9.05 2.22 -0.69 -4.33 13.91 -5.04
Earnings Per Share(Adj)-Unit Curr -9.05 2.22 -0.69 -4.33 13.91 -5.04
Book Value 24.38 34.07 27.28 19.22 15.49 1.54
Book Value(Adj)-Unit Curr 24.38 34.07 27.28 19.22 15.49 1.54

Shareholding Pattern

  • Promoter Group

    58.45%

  • Public Share Holding

    41.55%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 15,745,631 43.55 15,745,631 4
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,386,586 14.90 5,386,586 10
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 21,132,217 58.45 21,132,217 14
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 700 0.00 50 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 1,000 0.00 500 3
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 55,000 0.15 55,000 2
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 101,000 0.28 100,000 2
Mutual Funds / UTI 3,400 0.01 0 4
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 132,651 0.37 132,651 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 293,751 0.81 288,201 16
2] Non Institution
Bodies Corporate 1,539,996 4.26 1,539,134 141
Clearing Members 534,680 1.48 534,680 19
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 384,516 1.06 379,559 262
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 793,404 2.19 793,296 547
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,640,664 10.07 3,640,664 66
Individuals holding nominal share capital up to Rs. 1 lakh 7,645,933 21.15 7,457,867 24,813
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 14,726,743 40.73 14,532,750 25,855
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 36,152,711 100.00 35,953,168 25,885

Company Background

Lyka Labs LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Lyka Labs Ltd
  • BSE Code : 677.0
  • ISIN : INE933A01014

  • Incorporation Year

    1976

  • Registered Office

    4801/B & 4802/A
    GIDC Industrial Estate, Ankleshwar,
    Gujarat-393002

  • Telephone

    91-02646-221422/220549

  • FAX

    91-02646-250692

  • Chairman

    Babulal Jain

  • Managing Director

    KUNAL NARENDRA GANDHI

  • Company Secretary

    Shailendra Kumar Agrawal

  • Auditor

    D Kothary & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Sharex Dynamic (India) Pvt Ltd
    C-101 247 Park ,
    L B S Marg ,Vikhroli West
    Mumbai - Mumbai - 400083

Lyka Labs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Lyka Labs 75.00 124.88 120.91 -10.40 0.00
Abbott India 25,805.30 7,217.19 6,929.05 33.96 43.78
Astrazeneca Phar 6,340.60 2,304.07 2,275.58 93.45 27.86
Glaxosmi. Pharma 2,573.30 3,932.76 3,790.20 41.11 58.17
Novartis India 1,719.85 393.10 354.33 43.43 15.94
Cipla 1,392.20 20,102.60 18,979.95 42.43 13.88
Bliss GVS Pharma 637.90 773.53 729.81 41.58 12.51
Amrutanjan Healt 499.35 520.13 502.55 26.75 24.16
Fermenta Biotec. 427.55 474.15 450.25 19.96 18.77
Guj. Themis Bio. 377.25 168.25 165.82 100.87 18.05
Ambalal Sarabhai 34.90 19.52 3.94 64.63 6.77